Moreover, omics sciences have partially revealed the potential interactome of the hAPPSw isoform at the olfactory level as well as the disruption of the IκBα-NFκB p65 complex during the neurodegenerative process, providing molecular features that may be used as novel olfactory drug target candidates to treat AD. This evidence concerns the gene NFKBIA and Alzheimer disease.